[After miniaturization to the limit, a double phase estro-progestin with early reinforcement. Result of a study of a new contraceptive based on d-norgestrel].
D000293:Adolescent; D000328:Adult; D003276:Contraceptives, Oral / Q000494:pharmacology; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D004341:Drug Evaluation; D004717:Endometrium / Q000187:drug effects; D045166:Estradiol Congeners / Q000494:pharmacology; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D008875:Middle Aged; D009644:Norgestrel / Q000494:pharmacology
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D009644:Norgestrel
Après la miniaturisation "au plancher" l'oestro-progestatif a double palier et a renforcement précoce (résultats d'une étude avec un nouveau contraceptif à base de d-norgestrel)